Sahajanand Medical Technologies IPO GMP Today
Expected Gain: 12.21%
Sahajanand Medical Technologies IPO GMP Today, 15 October 2026
Sahajanand Medical Technologies IPO GMP today is ₹42. Based on the latest GMP figure supplied for this update, the grey-market premium of Sahajanand Medical Technologies IPO stands at ₹42 on 15 October 2026.
The previous day’s GMP has not been confirmed in the information supplied. Therefore, the daily GMP movement cannot be calculated reliably.
The IPO price band is ₹327 to ₹344 per share. Adding the latest reported GMP of ₹42 to the upper price band of ₹344 gives an indicative listing price of ₹386 per share.
Based on the upper price band, the indicative GMP-based gain is approximately 12.21%. This is an estimate based on the reported GMP and is not a guarantee of the actual listing price or return.
Sahajanand Medical Technologies Limited develops, manufactures and markets medical devices used in vascular and structural heart interventions. Its product portfolio includes coronary stents, coronary balloons, TAVI devices, occluders and peripheral drug-coated balloons.
The IPO is scheduled to open on 15 October 2026 and close on 19 October 2026. The tentative allotment date is 21 October 2026, and the tentative listing date is 23 October 2026.
Sahajanand Medical Technologies IPO GMP is unofficial and does not guarantee the actual listing price or investment returns.
Sahajanand Medical Technologies IPO Expected Listing Price
IPO Upper Price Band: ₹344
Latest GMP on 15 October 2026: ₹42
₹344 + ₹42 = ₹386
The indicative listing price based on the latest GMP is ₹386 per share. The actual listing price may be different.
Estimated Gain Percentage: (₹42 ÷ ₹344) × 100 = approximately 12.21%.
This calculation uses the upper end of the IPO price band and the latest reported GMP. GMP is unofficial and may change before the shares list.
Sahajanand Medical Technologies IPO GMP Trend
Sahajanand Medical Technologies IPO GMP is reported at ₹42 as of 15 October 2026, based on the latest figure supplied for this update.
The previous day’s GMP has not been confirmed in the information supplied. Therefore, the daily movement cannot be calculated reliably. Grey-market premiums are unofficial and can change frequently based on market sentiment and demand.
| GMP Date | IPO Price Band | GMP | Estimated Listing | Estimated Gain | Estimated Profit/Lot | Status |
|---|---|---|---|---|---|---|
| 15-Oct-2026 | ₹327–₹344 | ₹42 | ₹386 | 12.21% | ₹1,806 | Latest GMP |
| Previous Update | ₹327–₹344 | Not Confirmed | Not Calculated | Not Calculated | Not Calculated | Previous GMP Unconfirmed |
Estimated listing price is calculated as the upper IPO price band plus GMP. Estimated gain percentage is calculated as (GMP ÷ upper IPO price band) × 100. Estimated profit per lot is calculated as GMP multiplied by the number of shares in one lot. The figures are indicative and do not guarantee listing performance.
Sahajanand Medical Technologies IPO Details
| IPO Name | Sahajanand Medical Technologies IPO |
| Company | Sahajanand Medical Technologies Limited |
| Industry | Medical Devices and Healthcare Technology |
| IPO Type | Book Building Issue |
| Issue Structure | Offer for Sale (OFS) |
| Issue Size | ₹475.48 Crore |
| Shares Offered | 1,38,22,116 Shares |
| Fresh Issue | No; the issue is entirely an OFS |
| Face Value | ₹1 per share |
| Offer Price Band | ₹327–₹344 per share |
| Lot Size | 43 Shares |
| Minimum Investment | ₹14,792 at the upper price band |
| Exchange | NSE and BSE |
| Latest GMP | ₹42 on 15 October 2026 |
| Previous GMP | Awaiting Confirmation |
| Daily GMP Change | Awaiting Confirmation |
| Estimated Listing Price | ₹386 based on the upper price band |
| Estimated Gain | Approximately 12.21% |
| Estimated Profit Per Lot | ₹1,806 based on the reported GMP |
| IPO Open Date | 15 October 2026 |
| IPO Close Date | 19 October 2026 |
| Allotment Date | 21 October 2026* |
| Refund / Unblocking | 22 October 2026* |
| Demat Credit | 22 October 2026* |
| Listing Date | 23 October 2026* |
| Registrar | MUFG Intime India Private Limited |
| Book Running Lead Managers | Motilal Oswal Investment Advisors Ltd.; Avendus Capital Pvt. Ltd.; HSBC Securities & Capital Markets (India) Pvt. Ltd.; Nuvama Wealth Management Ltd. |
Dates marked with an asterisk are tentative. Please verify issue details against the latest official offer documents and exchange announcements.
Sahajanand Medical Technologies IPO GMP Profit Estimate
The latest reported GMP is ₹42 per share. The IPO lot size is 43 shares, and the upper end of the price band is ₹344. The following calculations are indicative and exclude charges and taxes.
| Particular | Calculation | Amount |
|---|---|---|
| IPO Investment at Upper Band | ₹344 × 43 Shares | ₹14,792 |
| Estimated Listing Price per Share | ₹344 + ₹42 GMP | ₹386 |
| Estimated Listing Value per Lot | ₹386 × 43 Shares | ₹16,598 |
| Indicative GMP-Based Gain per Lot | ₹42 × 43 Shares | ₹1,806 |
| Indicative Gain Percentage | (₹42 ÷ ₹344) × 100 | 12.21% |
These estimates use the upper price band and the latest reported GMP. The actual listing price may be higher or lower, and the realized return may differ due to market conditions, charges and taxes.
Sahajanand Medical Technologies IPO GMP Update
GMP Date: 15 October 2026
Latest GMP: ₹42
IPO Price Band: ₹327–₹344
Upper Price Band: ₹344
Estimated Listing Price: ₹344 + ₹42 = ₹386
Estimated Gain: 12.21%
Estimated Profit Per Lot: ₹1,806
The reported GMP of ₹42 is an unofficial indication of grey-market sentiment. It should not be treated as a confirmed listing premium or a guaranteed return.
The previous GMP has not been confirmed, so the daily change is not shown.
What Is Sahajanand Medical Technologies IPO GMP?
IPO GMP stands for Initial Public Offering Grey Market Premium. It refers to the unofficial premium at which IPO shares may be quoted in the grey market before their stock exchange listing.
A positive GMP means that grey-market participants are quoting a premium over the issue price. However, grey-market transactions are unofficial, and the reported premium can change with demand, market conditions and investor sentiment.
Estimated Listing Price = IPO Upper Price Band + Latest GMP
₹344 + ₹42 = ₹386
Estimated Gain (%) = (₹42 ÷ ₹344) × 100 = 12.21%
Estimated Profit Per Lot = ₹42 × 43 shares = ₹1,806
These formulas provide indicative calculations only. The actual Sahajanand Medical Technologies IPO listing price may be higher or lower than the GMP-based estimate. Investors should not make investment decisions based solely on GMP.
Sahajanand Medical Technologies Company Overview
Sahajanand Medical Technologies Limited is a medical technology company that develops, manufactures and markets medical devices used in vascular and structural heart interventions.
Its product portfolio includes coronary stents, coronary balloons, transcatheter aortic valve implantation (TAVI) devices, occluders, renal stents and peripheral drug-coated balloons. The company’s product brands include Supraflex Cruz, Cocoon and Hydra.
The company has three manufacturing facilities, including two in India and one in Thailand, along with research and development centres in India and Thailand. Its products are marketed internationally.
Investors should review the company’s revenue growth, profitability, debt levels, product approvals, competition, research and development activities and business risks before making an investment decision.
According to the issue information provided, the IPO is entirely an offer for sale. Consequently, the company will not receive proceeds from the sale of shares by existing shareholders.
Sahajanand Medical Technologies IPO Key Details
| Particular | Sahajanand Medical Technologies IPO Information |
|---|---|
| Company | Sahajanand Medical Technologies Limited |
| Industry | Medical Devices and Healthcare Technology |
| IPO Type | Book Building Issue |
| Issue Structure | Offer for Sale (OFS) |
| Issue Size | ₹475.48 Crore |
| Face Value | ₹1 per share |
| Price Band | ₹327–₹344 |
| Lot Size | 43 Shares |
| Retail Minimum Investment | ₹14,792 at the upper price band |
| Listing Exchange | NSE and BSE |
| Latest GMP | ₹42 on 15 October 2026 |
| Previous GMP | Awaiting Confirmation |
| Daily GMP Change | Awaiting Confirmation |
| Estimated Listing Price | ₹386 |
| Expected Gain | Approximately 12.21% |
| Expected Profit Per Lot | ₹1,806 before charges and taxes |
| IPO Opening Date | 15 October 2026 |
| IPO Closing Date | 19 October 2026 |
| Expected Allotment Date | 21 October 2026* |
| Expected Listing Date | 23 October 2026* |
Sahajanand Medical Technologies IPO Important Dates
| IPO Event | Date |
|---|---|
| IPO Opens | 15 October 2026 |
| IPO Closes | 19 October 2026 |
| Basis of Allotment | 21 October 2026* |
| Refund / Unblocking | 22 October 2026* |
| Shares Credited to Demat | 22 October 2026* |
| Listing | 23 October 2026* |
Dates marked with an asterisk are tentative and should be checked against the final IPO schedule and exchange notices.
Sahajanand Medical Technologies IPO GMP FAQs
What is Sahajanand Medical Technologies IPO GMP today?
The latest GMP supplied for this post is ₹42 on
15 October 2026. This is an unofficial grey-market indication.
What is the expected listing price of Sahajanand Medical Technologies IPO?
Based on the upper price band of ₹344 and a GMP of ₹42,
the indicative listing price is ₹386 per share.
What is the expected gain from Sahajanand Medical Technologies IPO GMP?
The indicative gain is approximately 12.21%, calculated as
₹42 divided by ₹344 and multiplied by 100.
What is the estimated profit per lot?
For a lot of 43 shares, the indicative GMP-based gain is
₹42 × 43 = ₹1,806 before charges and taxes.
What is the Sahajanand Medical Technologies IPO price band?
The price band is ₹327 to ₹344 per share.
What is the Sahajanand Medical Technologies IPO lot size?
The minimum lot size is 43 shares.
What is the minimum investment in Sahajanand Medical Technologies IPO?
At the upper price band of ₹344, the minimum investment for
one lot of 43 shares is ₹14,792.
When will Sahajanand Medical Technologies IPO open?
The IPO is scheduled to open on 15 October 2026.
When will Sahajanand Medical Technologies IPO close?
The IPO is scheduled to close on 19 October 2026.
When will Sahajanand Medical Technologies IPO allotment take place?
The tentative allotment date is 21 October 2026.
When will Sahajanand Medical Technologies IPO list?
The tentative listing date is 23 October 2026.
Who is the registrar of Sahajanand Medical Technologies IPO?
MUFG Intime India Private Limited is listed as the registrar
in the supplied IPO details. Please verify against the final
offer documents.
Is Sahajanand Medical Technologies IPO GMP reliable?
GMP is an unofficial market indication. It can fluctuate
significantly and does not guarantee the actual listing price
or investment returns.
Will Sahajanand Medical Technologies Limited receive IPO proceeds?
The supplied issue details describe the IPO as entirely an
offer for sale. Proceeds from the sale of shares will go to
the selling shareholders, not to the company.
Sahajanand Medical Technologies IPO GMP is based on an unofficial grey-market indication supplied for informational purposes. The reported GMP of ₹42 on 15 October 2026 is not an official exchange price or a guaranteed profit. The estimated listing price of ₹386, estimated gain of 12.21% and estimated profit per lot of ₹1,806 are calculations based on the upper price band of ₹344 and a lot size of 43 shares.
Actual listing performance may differ. GMP can change at any time and does not guarantee investment returns. IPO dates, price band, lot size, issue terms, registrar and other details should be verified against official offer documents and exchange announcements. Investors should conduct their own research and due diligence before making an investment decision.